Table 3: Incidence of ≥ Grade 3 adverse event in sunitinib-treated patients classified by age.
| Contents | Variable | P value | |||
| Age < 75 years (n=38) | Age ≥ 75 years (n=9) | ||||
| + | - | + | - | ||
| ≥Grade 3 in all Adverse Events | 30(79) | 8(21) | 9(100) | 0(0) | 0.1308 |
| ≥Grade 3 in symptoms | 9(24) | 29(76) | 5(56) | 4(44) | 0.0601 |
| ≥Grade 3 in Abnormal laboratory data | 25(66) | 13(34) | 5(56) | 4(44) | 0.5656 |